A new cell design, described as "plug-and-play", may potentially revolutionize cancer immunotherapy. However, reports on the specifics of the development and its applications are varied, with some outlets discussing its potential impact on pancreatic cancer, while others mention unrelated breakthroughs in cancer treatment, such as a wearable patch or a base-edited gene therapy. The exact nature and scope of the innovation are unclear, with different outlets highlighting different aspects of cancer research.